Global IV Solutions Market to Exceed US$15,906.0 Million by 2030


SEATTLE, August 19, 2022 /PRNewswire/ — According to Consistent market informationthe Global intravenous solutions market is estimated at US$9,907.8 million in 2022 and should present a CAGR of 6.1% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Intravenous Solutions Market:

The major players operating in the market are focusing on adopting growth strategies such as acquisitions and product launches which are expected to drive the growth of the market over the forecast period. For example, in December 2019Eurolife Healthcare, a pharmaceutical company, has completed the acquisition of the intravenous (IV) infusion business of Teva Pharmaceutical Industries, Hungary, a multinational pharmaceutical company, the acquisition will contribute to the company’s expansion in Europe and the US market.

Moreover, on July 12, 2022, B. Braun Medical Inc., an infusion therapy company, announced the launch of its new Introcan Safety 2 intravenous catheter with single blood control. The Introcan Safety 2 IV Catheter is B. Braun’s latest development to make IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood from the catheter hub after removal from the needle to the first connection of a Luer access device (the positive displacement feature is designed to help reduce catheter occlusions).

Request a sample copy of this report @

Main market takeaways:

The market players are focusing on growth strategies such as getting approval from respective country governments. This in turn is expected to boost the growth of the global market intravenous solutions market. For example, on February 3, 2022B. Braun Medical, an infusion therapy company, has received US FDA (Food and Drug Administration) approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida. Installation, which is part of the company’s commitment to spend 1 billion US dollars on its manufacturing and supply chain in the United States to address shortages of intravenous fluids.

Among the solution types, the saline solution segment is expected to account for a major share of revenue during the forecast period owing to the increasing prevalence of acute gastroenteritis. For example, in December 2021a report was published in (Microbial pathogenesis) ELSEVIER, academic publishing house, on the global prevalence of norovirus (virus that causes vomiting and diarrhea) in cases of acute gastroenteritis from 1997 to 2021: a review systematic review and meta-analysis, which report that the global prevalence of norovirus among acute gastroenteritis was 16% over the past 20 years, with children under 5 years of age at higher risk of norovirus.

Between region, North America is expected to hold a dominant position in the global intravenous solutions market over the forecast period, owing to the growing number of inorganic growth strategies by major market players in the region. For example, in May 2019B. Braun Medical Inc., an infusion therapy and pain management company, announced Solutions for Life, a software tools and consulting services company, a 1 billion US dollars investing in new and improved IV therapy manufacturing facilities to help ensure a reliable and consistent supply of vital IV fluids that America’s healthcare providers need. Investments include a new manufacturing plant in Daytona Beach, Floridaand modernization of existing facilities in Irvine, Californiaand Allentown, Pennsylvania.

Key players operating in the global IV Solutions market include Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, SA, Fresenius Kabi UNITED STATESLLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.

Customization request @

Detailed segmentation:

Global intravenous solutions market, by type of solution:

  • Saline
    • Normal saline solution (0.9% NaCl)
    • Hypertonic saline solution
  • Dextran
  • milky ringer
  • Amino acid
  • Vitamins & Minerals
  • Heparin and trace elements
  • Mixed solutions

Global IV Solutions Market, By Bag Type:

  • Large volume bags (greater than 250 ml)
  • Small volume bags (less than 250 ml)

Global Intravenous Solutions Market, By Application:

  • Basic IV solution
  • Nutritional IV Solution
  • IV blood solution
  • Medication IV Solution
  • IV irrigation solution

Global Intravenous Solutions Market, By End User:

  • Hospitals
  • Clinics
  • Ambulatory surgery centers
  • Home care settings

Global Intravenous Solutions Market, By Region:

  • North America
  • Europe
    • By country:
      • UK
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • By country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • By country:
      • GCC countries
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Buy this full report now @

Find the related trend report below:

Intravenous Access Devices Marketby product type (IV catheters, IV infusion pumps and IV needles), catheter (midline peripheral catheters, peripherally inserted central catheters, central inserted central catheters and others), end user (hospitals and clinics and ambulatory surgery centers) and by region (North America, Latin America, Europe, Asia Pacific, Middle Eastand Africa) – Size, Share, Prospects and Opportunities Analysis, 2019 – 2027

About Us:

Consistent market information is a global market intelligence and advisory organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office at Indiahaving a sales office in the financial capital of the world in the United States and sales advisers in UK and Japan. Our client base includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact us:
Mr Shah
Senior Client Partner – Business Development
Consistent market information
WE: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
E-mail: [email protected]
Follow us: LinkedIn | Twitter


SOURCE Consistent Market Information


Comments are closed.